The Hydration Pharmaceuticals Co (ASX:HPC) Common Stock: A$60.92 Mil (As of Dec. 2025)


What is The Hydration Pharmaceuticals Co Common Stock?

The Hydration Pharmaceuticals Co ASX:HPC Common Stock is A$60.92 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

The Hydration Pharmaceuticals Co's quarterly common stock declined from Dec. 2024 (A$62.64 Mil) to Jun. 2025 (A$40.32 Mil) but then increased from Jun. 2025 (A$40.32 Mil) to Dec. 2025 (A$60.92 Mil).

The Hydration Pharmaceuticals Co's annual common stock increased from Dec. 2023 (A$58.76 Mil) to Dec. 2024 (A$62.64 Mil) but then declined from Dec. 2024 (A$62.64 Mil) to Dec. 2025 (A$60.92 Mil).

The Hydration Pharmaceuticals Co Common Stock Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Common Stock Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
50.96 54.26 58.76 62.64 60.92

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only 58.76 39.94 62.64 40.32 60.92

The Hydration Pharmaceuticals Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$60.92 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Common Stock of A$60.92 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Common Stock too high?
The Hydration Pharmaceuticals Co's current Common Stock is A$60.92 Mil.
How does The Hydration Pharmaceuticals Co's Common Stock compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Common Stock of A$60.92 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Retail - Defensive company?
A good Common Stock depends on the Retail - Defensive industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Common Stock is A$60.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Common Stock of A$60.92 Mil. The current Common Stock is A$60.92 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Common Stock is A$60.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.